Tang Jin-Bao | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Tang Jin-Bao | Pharmacology | Best Researcher Award

Prof. Dr Tang Jin-Bao,Shandong Second Medical University,China

Prof. Dr. Jin-Bao Tang, a licensed pharmacist in China, is a professor at Shandong Second Medical University. He earned his Ph.D. in Microbial and Biochemical Pharmacy from Shandong University in 2023. An esteemed graduate sponsor in Shandong Province, he specializes in Biotechnological Pharmaceutics and Pharmaceutical Engineering. His research focuses on developing novel immunoassay biosensors for proteins and peptides. With multiple high-impact publications in Food Chemistry and Analytical Bioanalytical Chemistry, he has pioneered advanced immunosensor technologies. His innovative contributions to biosensor development enhance precision in food safety and biomedical analysis. 🔬📚

Publication Profile

Scopus

Education

Prof. Dr. Jin-Bao Tang 🎓 holds a Doctorate in Microbial and Biochemical Pharmacy from Shandong University (2023) and is a licensed pharmacist in China. As a distinguished professor at Shandong Second Medical University, he plays a vital role in educating future pharmaceutical professionals in Biotechnological Pharmaceutics and Pharmaceutics Engineering 🧪. His dedication to academia is evident through his mentorship and contributions to pharmaceutical sciences. Recognized as an excellent graduate sponsor of Shandong Province 🏆, Dr. Tang’s expertise and commitment continue to shape the next generation of researchers and industry leaders in the field of pharmacy. 💊

Scientific Community

Prof. Dr. Jin-Bao Tang 🧑‍🔬 has made a significant impact in the scientific community through his groundbreaking research in biotechnology and pharmacology. His publications appear in prestigious journals such as Food Chemistry, International Journal of Biological Macromolecules, Food Control, and Analytical Bioanalytical Chemistry 📚. His collaborative work has led to advancements in oriented antibody immobilization, photoconjugation strategies, and biosensor technology 🧪, with profound implications for public health, biotechnology, and pharmacological applications. Through his innovative contributions, Prof. Tang continues to shape the future of pharmaceutical sciences, enhancing diagnostic and therapeutic approaches for global healthcare. 🌍💊

Research Contributions

Prof. Dr. Tang Jin-Bao’s research revolves around developing novel immunoassay biosensors for protein and peptide detection 🧪🔬. His pioneering work has significantly advanced biosensing technology, particularly in food safety and biomedical analysis 🍎⚕️. Over the past five years, his high-impact publications have introduced innovative techniques such as electrochemical immunosensors for aflatoxin detection ⚡, bioluminescent immunoassays using antibody-nanoluciferase conjugates ✨, and Fc-specific antibody modifications for enhanced biosensor performance 🧫. Additionally, his photoconjugation strategies have led to stable fluorescent antibody fabrication 🌟. These breakthroughs contribute immensely to food safety, pharmaceutical analysis, and immunodiagnostics, demonstrating the real-world impact of his research. 🚀

Research Focus

Prof. Dr. Jin-Bao Tang’s research primarily focuses on biosensors 🧪, immunoassays 🏥, and antibody engineering 🧬 for food safety and biomedical applications. His work involves developing electrochemical immunosensors ⚡, bioluminescent assays 💡, and advanced antibody modifications 🏗️ to enhance the detection of harmful contaminants like aflatoxin B1 🍄⚠️. He explores oriented antibody immobilization 🎯 to improve sensitivity and specificity in bioanalytical methods. Additionally, his research extends to drug delivery systems 💊, particularly in pulsatile release formulations ⏳, using innovative polymers. His contributions advance food safety 🥗, biomedical diagnostics 🏥, and pharmaceutical technologies 💊 for global health and safety.

Publication Top Notes

A facile and effective electrochemical immunosensor based on controlled and oriented immobilization of natural antibodies for sensitive detection of aflatoxin B1

Development of a bioluminescent immunoassay based on Fc-specific conjugated antibody–nanoluciferase immunoreagents for determining aflatoxin B1

Fabrication of cysteine-modified antibodies with Fc-specific conjugation for covalent and oriented immobilization of native antibodies

Preparation of enteric capsules with pulsatile drug delivery potential using pullulan and polyacrylic acid resin III

Berat Cinar Acar | Biopharmaceutics | Best Researcher Award

Published on by Top Pharmaceutical

Berat Cinar Acar | Biopharmaceutics | Best Researcher Award 

Dr Berat Cinar Acar,Department of Biology,Turkey

🔬 Dr. Berat Çınar Acar is a dedicated biologist specializing in microbiology and environmental biotechnology. He earned his Ph.D. in Biology from Gazi University (2018), focusing on bioremediation of chromium in industrial wastewater. His M.Sc. (2012) explored β-glucosidase enzyme activity in Lactobacillus and Bifidobacterium species. Currently a lecturer at Gazi University, he has led and contributed to multiple scientific research projects on microbial biotechnology and environmental detoxification. His research advances sustainable solutions for pollution control and microbial enzyme applications. 🌍🧪

Publication Profile

google scholar

Education Information

Dr. Berat Cinar Acar 🎓 earned his Ph.D. in Biology from Gazi University’s Institute of Science on May 30, 2018. His doctoral research focused on beta-glucosidase enzyme activity and isoflavone hydrolysis in Lactobacillus and Bifidobacterium under the supervision of Assoc. Prof. Zehra Nur Yüksekdağ. He completed his M.Sc. in Biology at Gazi University in 2012 and obtained his B.Sc. in Biology from Niğde University in 2008. With a strong academic background, he currently serves as a Lecturer in the Department of Biology at Gazi University, contributing to research and education in the field of microbiology 🔬.

Academic Duties

Dr. Berat Çınar Acar is a dedicated faculty member 🏫 at Gazi University, Faculty of Science, Department of Biology, specializing in the field of biology 🔬. As a lecturer, he plays a vital role in academic research and education, guiding students in various biological disciplines 📚. His expertise spans microbiology, biotechnology, and environmental sciences, contributing to innovative studies on probiotics, enzyme activities, and bioremediation 🌱🦠. Dr. Acar’s commitment to scientific advancement and education continues to inspire future researchers and professionals, fostering a deeper understanding of biological sciences for sustainable solutions to global challenges. 🌍

Awards

Dr. Berat Cinar Acar 🏆 was honored with the Gazi University Rectorate Incentive Award in 2024 for his outstanding contributions to scientific research and academic excellence. This prestigious recognition highlights his dedication to advancing biological sciences and his impactful work in microbiology 🔬. As a distinguished academic at Gazi University, Dr. Acar continues to inspire students and researchers through his innovative studies and commitment to education 📚. His achievements reflect his passion for scientific discovery and his ongoing efforts to push the boundaries of knowledge in his field.

Certificate

Dr. Berat Cinar Acar 📜 has earned multiple prestigious certifications, showcasing his expertise in advanced scientific techniques. In 2023, he received Mikrobiyota Education and Real-Time PCR Training Certificates 🧬 from Krosgen. His international certification in ICP-OES OPTIMA (2017) reflects his proficiency in analytical instrumentation 🔬. Additionally, he completed the Oba Chemometrics Training in Antalya (2015) and gained expertise in GC-MS instrumentation and ChemStation software from Agilent Technologies in Ankara (2012). These certifications highlight his dedication to continuous learning and innovation in microbiology, biotechnology, and analytical sciences 🏅

Works

Dr. Berat Çınar Acar is an esteemed researcher with significant contributions to microbiology, nanotechnology, and environmental science 🧪🌍. His work spans antimicrobial activity, bioremediation, and probiotic research, with publications in top-tier journals like Microscopy Research and Technique and Water, Air, and Soil Pollution 📖🔬. He has explored green synthesis of silver nanoparticles, cold plasma applications for food safety, and bioreduction of heavy metals. His international conference presentations showcase innovations in probiotic enzyme activity and biosurfactants 🦠🛡️. Dr. Acar’s research advances biotechnology and public health, addressing critical environmental and food safety challenges. 🚀

Duties Performed in Projects

Dr. Berat Çınar Acar has contributed significantly to various scientific research projects, focusing on microbiology, biotechnology, and environmental sciences 🧪🌱. His work includes chromium detoxification via bioremediation, probiotic bacterial studies, and beta-galactosidase enzyme activity analysis. He has led projects on cold atmospheric plasma applications for pathogen inactivation, biosorption techniques, and the antibacterial properties of hydrogels infused with silver nanoparticles. Additionally, Dr. Acar investigates extracellular polysaccharide production in probiotic strains and the bactericidal effects of ozone and plasma treatments against clinical pathogens 🦠🔬. His research continues to advance sustainable and innovative scientific solutions for health and the environment. 🌍✨

Research Focus

Dr. Berat Çınar Acar specializes in microbiology 🦠, probiotics 🥛, enzyme activity 🧪, and environmental biotechnology 🌱. His research focuses on probiotic bacteria, particularly Lactobacillus and Bifidobacterium species, exploring their β-glucosidase and β-galactosidase enzyme activities. He also investigates bioremediation for heavy metal removal and the biological cementation of soils. Additionally, his work extends to antimicrobial activities 🔬, folate production, and nanotechnology-based green synthesis 🌿⚗️. His studies contribute to food biotechnology, environmental sustainability, and innovative biomedical applications, making his research crucial for human health, nutrition, and ecological balance.

Publication Top Notes

Probiotic properties of lactobacilli species isolated from children’s feces

β-Glucosidase activity and bioconversion of isoflavone glycosides to aglycones by potential probiotic bacteria

Cementation in a matrix of loose sandy soil using biological treatment method

Beta-Glycosidase Activities of Lactobacillus spp. and Bifidobacterium spp. and The Effect of Different Physiological Conditions on Enzyme Activity

Kimyasal yöntemlerle atık sulardan ağır metal giderimi

Investigation of Chromium (III) Adsorption on Acid-Treated Bentonite Evaluation of Kinetic/Thermodynamic Data

Bioreduction of Cr(VI) by Raoultella ornithinolytica BCA13 Obtained from Tannery Effluent

Lactobacillus cinsi bakteriler tarafından üretilen biyosürfektanların anti-biyofilm ve anti-mikrobiyal aktivitelerinin belirlenmesi

Analyzing antimicrobial activity of ZnO/FTO, Sn–Cu‐doped ZnO/FTO thin films: Production and characterizations

Lactobacillus ve bifidobacterium cinsi bakterilerin beta-glukozidaz enzim aktivitesi ve izoflavon hidrolizi

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Assoc. Prof. Dr Mahshid Malakootian, Rajaie cardiovascular medical and research center, Iran

Born on March 21, 1981, in Tehran, Iran, Dr. Mahshid Malakootian is a distinguished molecular geneticist and Associate Professor at Rajaie Cardiovascular Medical & Research Institute, Tehran. A prolific researcher, she specializes in non-coding RNAs, cardiovascular genetics, and bioinformatics. She completed her Ph.D. in Molecular Genetics at Tarbiat Modares University and held postdoctoral fellowships at McGill University and Case Western Reserve University. Dr. Malakootian has published extensively and received numerous accolades, including Best Young Researcher awards. Fluent in English and Persian, she is a dedicated academic, head of the Cardiogenetic Research Center, and an editorial board member. 📚🧬🌍

Publication Profile

google scholar

Academic Excellence

Assoc. Prof. Dr. Mahshid Malakootian is a distinguished expert in molecular genetics and cardiogenetics, contributing significantly to the field. Since 2021, she has served as an Associate Professor at the Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran. 💡 From 2018, she has led the center as its Head, advancing groundbreaking research in cardiovascular genetics. 🧬 Previously, she was an Assistant Professor from 2015 to 2021 and has been an active board member of the Research Deputy since 2015, shaping impactful scientific initiatives. 📚 Her work continues to drive innovation in cardiovascular health. ❤️

Research Experience

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished molecular geneticist with extensive research experience. She pursued her post-doctorate in Experimental Medicine at McGill University, Canada (2016-2017), focusing on PCSK7 RNA regulators 🧬. Previously, she was a post-doctoral fellow at Tarbiat Modares University, Tehran (2014-2015), and a visiting research scholar at Case Western Reserve University, USA (2011-2012) 🔬. Dr. Malakootian earned her Ph.D. (2009-2014) and M.Sc. (2004-2007) in Molecular Genetics at Tarbiat Modares University, where she explored non-coding RNAs and tumorigenesis. Her academic journey began with a B.Sc. in Cellular and Molecular Sciences from the University of Tehran (1999-2003) 🧪.

Honors and Awards

Assoc. Prof. Dr. Mahshid Malakootian is an award-winning researcher recognized for her outstanding contributions in molecular genetics and stem cell technology. 🏆 She has earned accolades such as the “Best Young Researcher” award (2017, 2019) and the “Top Thesis Award” (2014). 🎖 Her pioneering research is supported by multiple grants, including studies on noncoding RNAs and cardiovascular biomarkers. She has discovered and sequenced numerous novel genetic variants, published in GenBank, and co-authored a U.S. patent for miR-her2-1, aiding breast and ovarian cancer diagnostics. 💡📚 A scholar of exceptional caliber, Dr. Malakootian remains a trailblazer in biomedical innovation. 🌟

Professional Societies

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished scientist and an active member of prestigious organizations, including the American Association for Cancer Research (AACR) 🌟, the Iranian Genetics Society (IGS) 🧬, and the Iranian Biotechnology Society 🌿. Her dedication to advancing research is reflected in her role as an editorial board member of the Environmental Health Engineering and Management Journal 📚. With her extensive expertise and contributions, she continues to shape the fields of cancer research, genetics, and biotechnology, fostering innovative solutions for global health challenges 🌍. Dr. Malakootian’s work exemplifies excellence and inspires the scientific community. ✨

Teaching Experience

Associate Professor Dr. Mahshid Malakootian is a distinguished expert in molecular genetics at Shahed University, where she also leads the Advanced Molecular Genetics Lab Course 🧬. Her dedication to education and research has inspired countless students and colleagues. Dr. Malakootian has honed her expertise as a research assistant in Dr. Mowla’s laboratory, contributing to cutting-edge discoveries in molecular genetics 🔬. With a passion for advancing knowledge, she has made significant strides in her field, combining academic excellence with hands-on laboratory experience. Her work continues to shape the future of genetic research and education, making her a respected figure in the scientific community.

Research Focus

Assoc. Prof. Dr. Mahshid Malakootian focuses on cutting-edge research in microRNAs, cardiovascular diseases, and non-coding RNAs in various biological and pathological contexts. Her work explores microRNA roles in cardiovascular development, post-transcriptional regulation, and cancer biology, particularly lung and esophageal tumors. Dr. Malakootian also investigates long non-coding RNAs (lncRNAs), circular RNAs, and their interplay in genetic regulation and disease pathways. Her studies on epigenetics and innovative therapeutic approaches significantly impact cardiovascular health and cancer treatment. 🧬🩺🫀

Publication Top Notes

MicroRNAs: roles in cardiovascular development and disease

Post-transcriptional regulation of PCSK9 by miR-191, miR-222, and miR-224

Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors

Ciprofloxacin removal from aqueous media by adsorption process: a systematic review and meta-analysis

Pathophysiology, Diagnosis, Treatment, and Genetics of Carpal Tunnel Syndrome: A Review

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma

Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report

Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors

lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells

Roxana Matran | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Roxana Matran | Pharmacology | Best Researcher Award

Assist Prof Dr Roxana Matran, UMF “Carol Davila”, Romania

Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic with a Ph.D. from Carol Davila University of Medicine and Pharmacy (2017) 🎓. An Assistant Professor at the same university since 2019, she excels in teaching and research on pediatric pulmonology and gastroenterology. Her clinical expertise at “Grigore Alexandrescu” Emergency Hospital for Children includes contributions to groundbreaking clinical trials on inflammatory bowel diseases 🏥🔬. A dedicated volunteer with MD Caravana cu Medici 🤝, she brings healthcare to underserved communities. Dr. Matran’s active membership in ESPGHAN and advisory roles showcase her impactful influence in public health policy 🌍✨.

Publication Profile

orcid

Educational Backgrounds

Assist. Prof. Dr. Roxana Matran embarked on her academic journey at the prestigious Central School in Bucharest, where she specialized in Mathematics-Informatics with bilingual French instruction (📘✏️). She continued her education at “Carol Davila” University of Medicine and Pharmacy, earning a Bachelor’s Degree in 2009 (🎓🩺). Driven by her passion for medicine, she pursued a Ph.D. at the same university, completing her thesis on factors contributing to pulmonary disease in cystic fibrosis between 2013 and 2017 (📄🫁). Her dedication and expertise in the medical field have solidified her reputation as a leading academic and researcher in Bucharest (🌟🏥).

Work Experiance

Assist. Prof. Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic based in Bucharest. She serves as a member of the Advisory Committee on Post-Vaccination Adverse Reactions, analyzing vaccine-related health concerns (💉📊). She is also a sub-investigator in pivotal clinical trials, including studies on Vedolizumab and Adalimumab for pediatric Crohn’s disease and ulcerative colitis (🔬📑). Dr. Matran volunteers with Caravana cu Medici, offering medical consultations in underserved Romanian villages (🚑🤝). As an Assistant Professor at “Carol Davila” University, she teaches fifth-year medical students and conducts extensive research (📚👩‍🔬). Her work at “Grigore Alexandrescu” Emergency Hospital focuses on consultations, rounds, and clinical studies (🏥👶).

Membership

Assist. Prof. Dr. Roxana Matran is an active member of esteemed professional organizations in her field. Since June 2019, she has been a Full Member of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN), contributing to advancements in pediatric healthcare across Europe (🌍👶🩺). Additionally, she has been a dedicated member of the Romanian Society of Pediatrics since July 2016, working to promote excellence in pediatric medicine and research in her home country (🇷🇴📚💉). Her involvement in these societies underscores her commitment to improving children’s health and staying at the forefront of medical advancements (🌟🔬).

Conference and Seminars

Assist. Prof. Dr. Roxana Matran has an extensive track record of participation in prestigious medical events and specialized training programs worldwide. In 2024, she is set to attend the 5th Liver Transplant School in Brussels (25–28 September) and the ESPGHAN Mastercourse in Parenteral Nutrition in Linz, Austria (4–6 March). Her prior engagements include the ESPGHAN IBD Masterclass in Helsinki, Finland (2022) and the International Symposium on Pediatric Inflammatory Bowel Disease in Edinburgh, Scotland (2022). Over the years, she has honed her expertise in pediatric gastroenterology, nutrition, and pulmonology, attending courses in Italy 🇮🇹, Austria 🇦🇹, France 🇫🇷, and Greece 🇬🇷, and even completing a post-graduate program online 🌐.

Community Impact

Assist. Prof. Dr. Roxana Matran is deeply committed to serving underserved communities, demonstrating her passion for equitable healthcare access. She actively volunteers with MD Caravana cu Medici, a noble initiative providing essential medical consultations in impoverished Romanian villages 🏡. Through this work, Dr. Matran brings her expertise in pediatric gastroenterology and nutrition to those who need it most, offering care, guidance, and hope 🌟. Her dedication to improving public health goes beyond the clinic, reflecting a strong sense of compassion and responsibility toward marginalized populations 🤝. Dr. Matran’s efforts exemplify the true spirit of community service and medical care ❤️.

Clinical Expertise

Assist. Prof. Dr. Roxana Matran has made significant contributions to pediatric gastroenterology through her clinical practice, research, and involvement in clinical trials. As a pediatric gastroenterologist at “Grigore Alexandrescu” Emergency Hospital for Children 🏥, she seamlessly combines patient care with groundbreaking research. Dr. Matran has actively contributed as a subinvestigator for leading pharmaceutical companies, including Takeda Pharmaceuticals (VedolizumabSC-3003) and AbbVie (Adalimumab), advancing therapies for pediatric inflammatory bowel disease 🔬. She also researches post-vaccination adverse reactions as a member of the Advisory Committee at the Ministry of Health, ensuring better health outcomes for children globally 💉.

Research Focus

Dr. Roxana Elena Smădeanu’s research focus primarily revolves around pediatric health, with a special emphasis on diagnosing and managing complex diseases such as cystic fibrosis, intestinal tuberculosis, and respiratory conditions in children. Her work includes exploring microbiota’s role in functional abdominal pain disorders, respiratory symptomatology associated with COVID-19 in pediatric patients, and rare genetic syndromes like Menke-Hennekam syndrome. Additionally, her research delves into diagnostic methods like sweat conductivity in cystic fibrosis. This body of work aligns with clinical and laboratory research aimed at improving pediatric healthcare and diagnostics. 🧑‍🔬🩺👶

Publication Top Notes

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center

Food Related Quality of Life in Children with Chronic Gastrointestinal Disorders: Comparative Study Between Inflammatory Bowel Disease and Celiac Disease—Reports from a Romanian Center

Anti TNF-a Use in Pediatric Inflammatory Bowel Disease – Reports from a Romanian Center

Quality of Life of Pediatric Patients with Chronic Intestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic

Menke–Hennekam Syndrome: A Literature Review and a New Case Report

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Mr Victor Ajayi, University of Medical sciences Ondo Nigeria, Nigeria

Mr. Oluwadamilola Victor Ajayi is a distinguished academic and researcher in human physiology 🧬, with a B.Tech, M.Sc., and M.Phil. from reputable institutions. His groundbreaking research focuses on anti-ulcerogenic and antioxidant effects, phytochemical profiling, and bioactive compounds’ therapeutic roles 🩺. With over a decade of teaching experience at UNIMED 🎓, he excels in curriculum development and research mentorship. A member of esteemed bodies like PSN and Physoc 🏅, Mr. Ajayi actively engages in advancing physiology through publications and conferences. His dedication to science and education makes him a standout contributor in his field 🌍.

Publication Profile

orcid

Educational Backgrounds

Victor Ajayi’s academic journey spans several prestigious institutions. He is currently pursuing an M.Phil in Human Physiology at the Federal University of Technology, Akure (FUTA), starting in November 2024. He previously attended the University of Medical Sciences (UNIMED), Ondo, from August 2022 to December 2024, and earned his M.Sc. in Human Physiology from the University of Ibadan in November 2018. Victor completed his B.Tech in Human Physiology at Ladoke Akintola University of Technology (LAUTECH) in November 2011. His earlier academic milestones include WAEC (2009) and NECO (2002). 🎓📚👨‍🎓

Work Experience

Victor Ajayi has a diverse work experience spanning various roles in academia and healthcare. He started with industrial training as a Technologist at Spring Specialist Hospital in 2010, followed by NYSC at Ondo State School of Nursing, where he taught Physiology and Anatomy. Victor later worked as a teacher and guest tutor at different institutions, including Integrity Nursery, Ondo State School of Nursing, and several colleges. At the University of Medical Sciences, he serves as an Assistant Lecturer, course coordinator, and level adviser, while also supervising graduate students. His contributions to Physiology education remain invaluable. 🏥📚👨‍🏫

Membership

Mr. Victor Ajayi D. is an active member of esteemed professional bodies such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc). Over the years, he has attended several notable conferences and workshops, including the 28th and 29th Scientific Conferences of PSN at the University of Ilorin in 2008 and 2009, and the 31st conference at Lagos State University in 2011. He also participated in workshops on pedagogy, effective communication, animal ethics, and integrated registration. His dedication to continued learning is evident in his certified seminar attendance, such as the Bioinformatics and Genomics course in October 2024. 📚🔬🧑‍🏫

Community and Professional Engagement

Mr. Victor Ajayi has consistently showcased remarkable leadership in professional communities. As a dedicated member of esteemed organizations such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc), he has made significant contributions to the advancement of his field. His active participation in numerous conferences and workshops underscores his commitment to continuous learning and staying at the forefront of his profession. Through these engagements, Mr. Ajayi has demonstrated a passion for professional growth and a commitment to fostering collaboration within the scientific community. His involvement continues to inspire and influence others in the field. 💼📚

Accolades and Recognition

Mr. Victor Ajayi has made significant contributions to research, education, and professional development, positioning him as a strong contender for the Best Researcher Award. Although his CV does not highlight specific prior awards, his innovative approaches to addressing physiological challenges and his commitment to advancing scientific knowledge demonstrate his potential. Additionally, his dedication to mentoring the next generation of researchers reflects his passion for nurturing talent and fostering academic growth. Mr. Ajayi’s work continues to inspire and impact the research community, showcasing his outstanding ability to drive change and innovation in his field. 🏆📚🔬

Research Focus

Mr. Victor Ajayi’s research focuses on the anti-inflammatory and anti-oxidative effects of pasteurized yoghurt in mitigating gastric ulceration induced by indomethacin in male Wistar rats. This study delves into gastrointestinal health and the potential therapeutic benefits of food-based interventions in inflammatory conditions. His work contributes to pharmacology, nutritional science, and biomedical research with an emphasis on how diet and natural substances can influence disease progression and provide alternative treatments. This aligns with the field of Pharmacological Toxicology and Gastroenterology, exploring the intersection of nutrition and pharmacology in disease management. 🧑‍⚕️🍽️💊

Publication Top Notes

Anti-inflammatory and anti-oxidative effect of pasterurised yoghurt in indomethacin induced gastric ulceration in male Wistar rats

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Dr Michael Swedberg, Swedberg Preclinical Partner, Sweden

Dr. Michael Swedberg is a distinguished pharmacologist with extensive expertise in safety pharmacology, CNS pharmacology, gastrointestinal pharmacology, and drug abuse assessment. He has held key leadership roles, including Associate Director at AstraZeneca and founder of Swedberg Preclinical Partner AB. His global impact includes contributions to regulatory compliance, developing novel animal models, and mentoring future researchers. With a Ph.D. in discrimination learning and postdoctoral training at NIDA, Dr. Swedberg has collaborated internationally and received numerous accolades for his innovative research and leadership. His career embodies excellence in pharmacology and preclinical drug discovery. 🌍💊🔬

Publication Profile

scopus

Education

Dr. Michael Swedberg is a distinguished academic and researcher, having earned his Ph.D. in 1985 from the University of Uppsala, Sweden. His doctoral dissertation focused on “A Model of Discrimination Learning with Interoceptive Stimuli.” He completed his postdoctoral fellowship at the National Institutes of Health (NIH), specializing in addiction research at the National Institute on Drug Abuse’s Preclinical Pharmacology Branch in Baltimore, Maryland (1985–1988). Additionally, Dr. Swedberg holds a Bachelor of Social Science (B.S.Sc.) from Uppsala University, with a comprehensive background in psychology, sociology, and law. 🧠📚🎓

Professional Appointments

Dr. Michael Swedberg has had an extensive and distinguished career in pharmacology and drug discovery. From 2014 to 2021, he was the Founder and CEO of Swedberg Preclinical Partner AB in Sweden. Prior to that, he was a Partner and Consultant at The Research Network (TRN) from 2014 to 2016. His earlier career includes key roles at AstraZeneca R&D, where he served as Associate Director in Safety Pharmacology and Preclinical Development. He also held senior leadership positions at Novo Nordisk and Ferrosan. Dr. Swedberg’s journey began as a Lecturer at Mälardalen University in 1981. 🧑‍🔬💉📚

Academic Service

Dr. Michael Swedberg has made significant contributions to the field of pharmacology and neuroscience through various roles. He served as a board member for the Department of Psychology at the University of Uppsala and the Faculty of Social Sciences from 1980 to 1985. His leadership extended to chairing the Council of Graduate Students. Recognized for his service, Dr. Swedberg received awards from the Drug Abuse Liability Ad Hoc Committee and for his work with the Lilly–Novo Nordisk Muscarinic Research Collaboration. He has also been a grant evaluator for the European Union and Poland’s National Centre for Research and Development. 🌍🔬🧠

Presentations

Dr. Michael Swedberg has made significant contributions to the field of drug safety and abuse liability assessment. His research, presented at multiple prestigious meetings, includes the role of drug discrimination studies in evaluating novel compounds’ abuse potential. Notably, his work at the Safety Pharmacology Society, American College of Toxicology, and the Swedish Pharmaceutical Congress has advanced methodologies like rat self-administration and drug discrimination for psychoactive effects. His work on the interaction between mGluR5 antagonists and benzodiazepines also stands out. Swedberg’s contributions to safety pharmacology have had a lasting impact on CNS drug development and regulatory guidelines. 🧠💊

Lecturing and teaching

Dr. Michael Swedberg has delivered extensive lectures and seminars on safety pharmacology, drug abuse, and CNS risk assessment. His contributions include lectures at the American College of Toxicology, Safety Pharmacology Society, and the European Congress of Toxicologic Pathology, focusing on drug dependence, abuse liability, and CNS safety. Additionally, Swedberg has provided in-depth training on the regulatory and industrial challenges in drug development at AstraZeneca and other global platforms. His teaching spans from the biomedical program at Karolinska Institute to the University of Uppsala, covering neuropharmacology, psychopharmacology, and drug addiction. His educational materials are widely respected in the field. 🧠📚💊

Academic Supervision

Dr. Michael Swedberg has mentored numerous students at various stages of their academic careers, including graduate, Ph.D., and postdoctoral researchers. He supervised students at Umeå University, University of Uppsala, and Karolinska Institute, guiding experimental work in fields such as cannabinoid tolerance, dopamine release, and nicotine’s effects on learning. His postdoctoral supervision included projects on visual and auditory discrimination in drug testing. Swedberg’s research has been supported by multiple prestigious grants, such as the Clas Groschinsky Memorial Foundation and the Swedish Medical Research Council. His contributions have significantly advanced brain and behavior research. 🎓🧠💡

Committee Service

Dr. Michael Swedberg held several key roles at AstraZeneca, including membership in the Safety Knowledge Group for CNS and leadership in CNS GLP Safety Pharmacology Harmonization. He was also a part of multiple committees, such as the AstraZeneca Expert Advisory Group on Abuse Liability and the Cross Company Abuse Liability Consortium. Dr. Swedberg contributed to international organizations like PhRMA and CPDD, focusing on drug abuse liability. He attended professional courses in safety pharmacology, project management, and leadership, further enhancing his expertise. Additionally, he completed a teaching course at Karolinska Institute, strengthening his academic influence. 🧠💊🎓

Research Focus

Dr. Michael Swedberg’s research focuses on the pharmacology of muscarinic receptors and their potential therapeutic applications, particularly in relation to neurological and psychiatric disorders. His work has delved into muscarinic receptor agonists, with significant contributions to the understanding of their antipsychotic and antinociceptive properties. Additionally, he has explored the role of nicotinic compounds and their reinforcing effects. His research has implications for treating conditions like schizophrenia, Alzheimer’s disease, and irritable bowel syndrome. 🧠🔬💊 His studies on receptor-ligand interactions and pharmacological profiles contribute to the development of novel drugs for various neurological and gastrointestinal conditions.

Publication Top Notes

Approaches for early identification of abuse potential liability

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Drug Discrimination: Use in Preclinical Assessment of Abuse Liability

AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Dr. Rahul Reddy|Pharmacology|Excellence in Research

Published on by Top Pharmaceutical

Dr.RahulReddy|Pharmacology|Excellence in Research

Dr. Rahul Reddy at Lautoka Hospital ,Fiji

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Rahul Krishna Reddy, a passionate medical professional, laid the foundation of his academic journey at Lautoka Andhra Sangam Primary School, where he studied from 2000 to 2008. He then progressed to Natabua High School (2009–2013), excelling academically and developing a keen interest in the medical sciences. His educational journey gained international momentum when he pursued a Chinese language program (HSK Level 4) at Shandong University in 2013–2014. This preparatory phase was instrumental in equipping him with linguistic skills for his future studies in China.

Rahul enrolled at Dalian Medical University (2014–2019), where he earned his MBBS degree. His time at Dalian was marked by rigorous academic training and multiple internships, including at the First Affiliated Hospital of Dalian Medical University. This exposure to advanced medical systems honed his clinical skills and solidified his career in surgery and medicine.

Professional Endeavors 🩺

Rahul’s professional journey is a testament to his dedication and commitment to the healthcare field. His initial post-MBBS years were spent at renowned institutions, including the Colonial War Memorial Hospital and Lautoka Hospital, where he completed intensive internship programs (2019–2021). These internships provided him with hands-on experience in diverse medical and surgical disciplines.

From 2021 to 2022, he played a crucial role in Fiji’s fight against COVID-19 as part of the Nadroga/Navosa COVID Team, showcasing his adaptability and resilience in public health crises. Later, as a Medical Officer at Vatukarasa Health Center (2022–2023), Rahul delivered primary care services, demonstrating his ability to cater to the diverse medical needs of his community. Currently, he serves as a Surgical Registrar at Lautoka Hospital, focusing on complex surgical cases and contributing significantly to patient outcomes.

Contributions and Research Focus 🔬

Rahul has made significant strides in clinical research, focusing on improving healthcare outcomes in Fiji. His studies have explored critical areas such as burn injuries, appendicitis, and innovative surgical techniques. Notable publications include:

  • Burns Injury Characteristics and Outcomes at Lautoka Hospital, highlighting critical insights into managing burn patients in resource-limited settings.
  • Research on acute appendicitis outcomes, offering data-driven recommendations for improving surgical care in Fiji.
  • Pioneering work on laparoscopic radical prostatectomy, reflecting his interest in minimally invasive surgery.
  • Contributions to the understanding of rare cases like primary epithelioid hemangioendothelioma and seminal vesicle cystadenoma through internationally recognized publications.

Rahul’s commitment to research and evidence-based practice demonstrates his dedication to advancing medical science in the Pacific region.

Accolades and Recognition 🏆

Rahul’s work has been recognized both nationally and internationally. In 2024, he won the Outstanding Young Investigator Award at the Fiji Medical Association Research Conference. His impactful presentations at conferences, including the Diabetic Foot Symposium and the Pacific Islands Health Research Symposium, have established him as a thought leader in surgical and public health topics.

Rahul has also actively participated in workshops, such as the EMSB and Pain Management sessions, further enhancing his clinical expertise. His continued professional development reflects his commitment to lifelong learning.

Impact and Influence 🌏

Rahul’s influence extends beyond the operating room. As a healthcare provider in Fiji, he has been instrumental in improving patient care and mentoring junior medical staff. His research contributions address key regional healthcare challenges, ensuring evidence-based practices are integrated into daily medical routines.

During the COVID-19 pandemic, his involvement in the Nadroga/Navosa COVID Team was pivotal in managing the outbreak, reflecting his leadership skills and community dedication.

Legacy and Future Contributions 🚀

Rahul Krishna Reddy is poised to leave a lasting legacy in the medical field. His combination of clinical expertise, research acumen, and community service positions him as a trailblazer in Fijian healthcare. Looking ahead, Rahul envisions expanding his contributions to global medical research, particularly in surgical innovation and healthcare systems in resource-limited settings.

His unwavering dedication to improving healthcare outcomes and fostering medical education ensures his enduring impact. As he continues to grow professionally, Rahul exemplifies the values of compassion, innovation, and excellence in medicine.

Conclusion 🌟

From his early academic achievements to his current role as a Surgical Registrar, Rahul Krishna Reddy’s journey reflects an unwavering commitment to healthcare. His research and clinical endeavors are paving the way for improved medical practices in Fiji and beyond. Rahul’s accomplishments and aspirations set a high standard for the next generation of medical professionals, cementing his position as a leader in the field.

🎓Publication 

Laparoscopic excision of seminal vesicle cystadenoma

  • Authors   : Qi Zhen Tang, Zhong Lin, Rahul Krishna Reddy, Zhi Wei Zhang
  • Journal    : Urology Case Reports
  • Year         :2019

Burns injury characteristics and outcomes at lautoka hospital, fiji

      • Authors   : Rahul Krishna Reddy, Arun Murari, Akhtar Ali, Ronal Kumar, Livai Lutunaika, Abhay Choudhari, Swastika Devi, Famiza Kulsum
      • Journal    : Burns Open
      • Year         :2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study

  • Authors   : Rahul Krishna Reddy, M Arun, K Ronal, Akhtar Ali, Livai Lutunaika, Y Devi Chandra
  • Journal    : World J Surg Surgical Res
  • Year         :2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis

  • Authors   :Rahul Reddy
  • Journal     : American Journal of Surgery and Clinical Case Reports
  • Year         :2020                                                                                                                                                                                                                                                 

Prof. Maysoon Al-Haideri| Drug Discovery |Best Researcher Award

Published on by Top Pharmaceutical

Prof. Maysoon Al-Haideri|Drug Discovery|Best Researcher Award

Prof. Maysoon Al-Haideri at University oh Kurdistan Hewlêr,Iraq

PROFILE  

scopus 

 

Early Academic Pursuits 🎓

Dr. Al-Haideri began her educational journey at Baghdad University, where she completed her B.Sc. in Pharmacy in 1973. She demonstrated early promise and a strong interest in clinical analysis, leading her to pursue an Advanced Diploma in Clinical Analysis from Baghdad University between 1977 and 1979. Her academic curiosity and pursuit of excellence took her to the United States, where she attended Columbia University in the City of New York, earning a Master of Arts (M.A.) in 1983, followed by an M.Phil. in Pathology in 1985. Her dedication and passion culminated in a Ph.D. in Pathology from Columbia University in 1987, marking the beginning of an illustrious career in clinical research and academia.

Professional Endeavors 🩺

Dr. Al-Haideri’s professional career began in Iraq, where she gained practical experience and took on leadership roles in several medical institutions. She completed a traineeship in Clinical Hematology, Clinical Biochemistry, Medical Microbiology, Parasitology, and Infectious Diseases at the Ministry of Health in Baghdad from 1974 to 1975. Following this, she served as the Director of the Clinical Laboratory at Abo-Alkhaseab Hospital in Basrah (1975-1976) and Chief of the Clinical Biochemistry and Hematology Divisions at Al-Khadmia Teaching Hospital in Baghdad (1976-1981). During this time, she was also responsible for student supervision and training, highlighting her commitment to fostering the next generation of healthcare professionals.

From 1981 to 1982, Dr. Al-Haideri took on a national role as the Director of Quality Control and Standardization for all public clinical laboratories in Iraq, ensuring the consistent application of best practices in clinical analysis. Her leadership and expertise were further recognized when she undertook a traineeship in infertility at the Ministry of Health in Baghdad in 1982, signaling her growing influence in medical diagnostics and reproductive health.

In the United States, Dr. Al-Haideri continued her impressive trajectory, completing a postdoctoral fellowship at North Shore University Hospital, Manhasset, New York (1987-1988), followed by research positions at Long Island Jewish Medical Center (1988-1990) and Albert Einstein College of Medicine, Bronx, New York (1989-1991). During this time, she held the title of Instructor of Immunology, Rheumatology, and Allergy. Dr. Al-Haideri’s academic and research career reached new heights when she joined Columbia University’s College of Physicians and Surgeons, where she worked as an NIH Postdoctoral Research Trainee (1991-1994), eventually becoming an Associate Research Scientist and Assistant Professor (1994-2004).

Contributions and Research Focus 🔬

Dr. Al-Haideri’s research has primarily focused on clinical pathology, immunology, rheumatology, and allergy. Her work has been instrumental in enhancing the understanding of immunological responses in various pathological conditions. She has been actively involved in numerous research projects, often collaborating with leading medical institutions in both the U.S. and Iraq.

Her role as Director of Quality Control and Standardization in Iraq’s Ministry of Health laid the groundwork for the development of national policies aimed at ensuring the accuracy and reliability of clinical laboratory diagnostics across the country. In the U.S., her work at prestigious institutions like Columbia University and Albert Einstein College of Medicine helped advance the field of immunology, particularly in relation to autoimmune diseases.

Accolades and Recognition 🏆

Dr. Al-Haideri’s work has been widely recognized through various awards and honors. She received NIH Grant Awards from 1991 to 1994, which supported her groundbreaking research in immunology and pathology. Her academic excellence was also acknowledged at Columbia University, where she was awarded Graduate Research Assistantships.

Her commitment to medical education and healthcare development in Iraq earned her numerous accolades, including being named Employee of the Year at Hawler Medical University in Erbil, Kurdistan in 2012. Additionally, she received letters of appreciation from the Minister of Higher Education and Scientific Research in the Kurdistan region, as well as from the President of Hawler Medical University and several deans of colleges at the university for her contributions to education and healthcare.

Impact and Influence 🌍

Dr. Al-Haideri has had a profound impact on medical education and healthcare both in Iraq and abroad. As a leader in various institutions, she has played a critical role in shaping the medical education system in the Kurdistan Region of Iraq. Her tenure as Dean of the College of Health Sciences at Hawler Medical University (2014-2018) and Director of Quality Assurance (2010-2015) helped set new standards for academic excellence and institutional leadership in the region.

Her influence extends beyond academia. Dr. Al-Haideri has been an active member of numerous professional societies, including the American Society for Biochemistry and Molecular Biology and the American Heart Association, further cementing her status as a respected expert in her field. Her involvement in international organizations, such as the International Institute of Education in New York, reflects her commitment to global collaboration and knowledge exchange.

Legacy and Future Contributions 🔮

Dr. Maysoon Tahir Al-Haideri’s legacy is one of dedication to advancing medical knowledge, improving healthcare systems, and fostering academic excellence. Her work has had a lasting impact on the clinical and academic landscapes in Iraq, particularly in the Kurdistan region, where she has influenced generations of healthcare professionals through her leadership roles at Hawler Medical University and Cihan University-Erbil.

As she continues her work as the Director of the Pharmacy Program at the University of Kurdistan Hewler, Dr. Al-Haideri remains committed to mentoring students and contributing to the development of the healthcare sector in the region. Her achievements serve as an inspiration to future generations of scientists, educators, and healthcare professionals, ensuring her legacy will endure for years to come.

🎓Publication 

Silymarin suppresses proliferation and PD-L1 expression in colorectal cancer cells and increases inflammatory CD8+ cells in tumor-bearing mice

  • Authors   :Al-Haideri, M.
  • Journal    :Clinics and Research in Hepatology and Gastroenterology
  • Year         :2024

Functional and financial analysis of an inclined step solar desalination using phase change nanomaterials

  • Authors   : Mahal, A., Al-Haideri, M., Alkhouri, A., Obaidullah, A.J., Duan, M.
  • Journal    :Water Science and Technology
  • Year         :2024

Tuning the optoelectronic properties of selenophene-diketopyrrolopyrrole-based non-fullerene acceptor to obtain efficient organic solar cells through end-capped modification

  • Authors   :Ijaz, R., Waqas, M., Mahal, A., … Alatawi, N.S., Aloui, Z.
  • Journal    :Journal of Molecular Graphics and Modelling,
  • Year         :2024

Rational designing of phenothiazine dioxide based hole transporting materials for efficient perovskite solar cells

  • Authors   : Hanan, M., Umair, Mahal, A., … Farooq, Z., Mahr, M.S.
  • Journal    : Solar Energy,
  • Year         :2024

Linking the increasing epidemiology of scrub typhus transmission in India and South Asia: are the varying environment and the reservoir animals the factors behind?

  • Authors   : Mohapatra, R.K., Al-Haideri, M., Mishra, S., … Mohanty, A., Sah, R.
  • Journal    :Frontiers in Tropical Diseases,
  • Year         :2024

Dr. Sukhendu Dey |Pharmacology |Best Researcher Award

Published on by Top Pharmaceutical

Dr. Sukhendu Dey|Pharmacology|Best Researcher Award

Dr. Sukhendu Dey at The University of Burdwan,India

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Dr. Sukhendu Dey was born on April 2, 1992, in West Bengal, India. He embarked on his academic journey with a deep interest in environmental sciences, obtaining a Ph.D. in Environmental Science. His focus areas during his doctoral studies included aquatic toxicology, fish hematology, and the use of biomarkers in environmental risk assessments.

Prior to his Ph.D., Dr. Dey completed his M.Sc. in Environmental Science, where he graduated with first-class honors. His consistent academic excellence also extended to a Post Graduate Diploma in Disaster Management, equipping him with the skills to address complex environmental challenges. Additionally, he earned a B.Ed. in Life Sciences, emphasizing his interest in education and knowledge dissemination.

Professional Endeavors 🔬

Currently serving as a Technical Assistant Gr.-II at The University of Burdwan, West Bengal, Dr. Dey plays a pivotal role in facilitating research and managing technical aspects of the university’s environmental science department. His 8-year research career has been supplemented by teaching experiences, where he imparted his knowledge in environmental toxicology and ecological sciences.

Dr. Dey’s professional focus lies in various interconnected areas of biochemistry, aquatic toxicology, risk assessment, and environmental toxicology. His research primarily revolves around understanding the biochemical impacts of pollutants on aquatic ecosystems, contributing to the development of new strategies for environmental preservation and sustainability.

Contributions and Research Focus 📚

Dr. Dey’s research contributions are both extensive and impactful. He has published over 30 research articles, 31 book chapters, and edited 5 books. His work spans across topics like biomarkers in aquatic systems, toxicity analysis, and the ecological impacts of pollutants.

Some of his significant research contributions are in the field of:

  • Fish Hematology: Understanding the blood parameters in fish as indicators of environmental stress.
  • Biomarkers: Developing methods to assess the health of aquatic environments through biochemical markers.
  • Aquatic Toxicology: Investigating the effects of chemical pollutants on aquatic organisms and ecosystems.

His scholarly publications are available on Google Scholar, where his research has been well-cited by peers across various domains, signifying the importance of his work in the scientific community.

Accolades and Recognition 🏅

Dr. Dey’s hard work and dedication have been recognized on numerous occasions. He was awarded the Environmental Research Excellence Award 2023 at the 9th International Conference on Environment and Ecology, a prestigious honor celebrating his contributions to environmental research. This accolade is a testament to his relentless pursuit of understanding and mitigating environmental issues.

Additionally, Dr. Dey has been an integral part of several conferences and seminars. He has organized and contributed to international and national-level seminars, workshops, and training programs on topics ranging from environmental crises to cutting-edge research techniques.

Impact and Influence 🌱

Dr. Dey’s influence extends beyond his research publications. He has actively participated in initiatives aimed at environmental conservation and sustainability. As a technical assistant at The University of Burdwan, he has mentored young researchers and students, fostering a new generation of environmental scientists.

He has played a significant role in organizing key events, such as the International Conference on Mother Earth: Save It to Achieve a Sustainable Future for All and the DST-PURSE Sponsored International Conference on Frontiers in Biological Environment and Medical Sciences. These efforts have brought together scientists, policymakers, and environmental advocates to discuss sustainable solutions for global environmental challenges.

In addition to his contributions at academic institutions, Dr. Dey is involved with the NGO Friends of the Earth (FOE), where he holds a lifetime membership. His work with the NGO reflects his commitment to using his scientific expertise for community-based environmental initiatives.

Legacy and Future Contributions 🚀

As Dr. Sukhendu Dey continues to explore the frontiers of environmental science, his legacy is one of passion, dedication, and impact. His research in aquatic toxicology and environmental toxicology has paved the way for better understanding the environmental risks posed by pollutants.

Dr. Dey’s future contributions are expected to expand further into the realm of environmental sustainability and risk mitigation, focusing on creating safer ecosystems and reducing the impacts of industrial and environmental pollutants.

Moreover, his involvement in interdisciplinary workshops and seminars indicates his desire to bridge the gap between research and practical applications, ensuring that his work has both scientific and societal relevance.

Conclusion 🌿

Dr. Sukhendu Dey’s career reflects an unwavering dedication to environmental science and its application in safeguarding ecosystems. From his early academic achievements to his ongoing professional endeavors, he has consistently contributed to the field of environmental toxicology. His awards, publications, and role in academic institutions mark him as a thought leader in his field, whose research has both national and international implications.

As a rising figure in environmental science, Dr. Dey’s legacy will continue to inspire future generations, promoting sustainability and environmental stewardship for years to come.

🎓Publication 

Integrative assessment of biomarker responses in teleostean fishes exposed to glyphosate-based herbicide (Excel Mera 71)

  • Authors   : Sukhendu Dey, Palas Samanta, Sandipan Pal, Aloke Kumar Mukherjee, Debraj Kole, Apurba Ratan Ghosh
  • Journal    :Emerging Contaminants
  • Year         :2016

Valorization of wastewater: A paradigm shift towards circular bioeconomy and sustainability

  • Authors   : Debajyoti Kundu, Deblina Dutta, Palas Samanta, Sukhendu Dey, Knawang Chhunji Sherpa, Sunil Kumar, Brajesh Kumar Dube
  • Journal    :Science of the Total Environment
  • Year         :2022

Dose specific responses of Anabas testudineus (Bloch) to anthracene (PAH): Haematological and biochemical manifestation

  • Authors   : Sukhendu Dey, Palas Samanta, Niladri Sekhar Mondal, Debraj Kole, Arghya Mandal, Atanu Patra, Apurba Ratan Ghosh
  • Journal    :Emerging Contaminants
  • Year         :2019

Time-Dependent Naphthalene Toxicity in Anabas testudineus (Bloch): A Multiple Endpoint Biomarker Approach

  • Authors   : Sukhendu Dey, Puspita Ballav, Palas Samanta, Arghya Mandal, Atanu Patra, Subhas Das, Arnab Kumar Mondal, Apurba Ratan Ghosh
  • Journal    :ACS omega
  • Year         :2020

Prof. Rasha Azzam|Drug Discovery and Development|Best Researcher Award

Published on by Top Pharmaceutical

Prof. Rasha Azzam|Drug Discovery and Development |Best Researcher Award

Prof. Rasha Azzam at Helwan University,Egypt

PROFILE  

orcid

Early Academic Pursuits 🎓

Prof. Rasha A. Azzam’s academic journey began with her outstanding performance in chemistry at Helwan University, Egypt, where she graduated with a Bachelor of Science (B.Sc.) in Chemistry in 1993. Her excellence in academia was recognized early on, as she graduated with class honors and was placed on the Dean’s List. Driven by her passion for organic chemistry, she pursued a Master of Science (M.Sc.) degree in Organic Chemistry at Helwan University, completing it in 1996. Her academic curiosity and dedication led her to further her studies internationally, earning a prestigious Ph.D. in Organic Chemistry in 2003 from the Catholic University of Leuven in Belgium. Her diverse educational background laid the foundation for a career defined by groundbreaking research and academic excellence.

Professional Endeavors 🧑‍🔬

Prof. Azzam’s professional career spans over two decades of teaching, research, and leadership in various prestigious academic institutions across the globe. She is currently a Professor of Organic Chemistry at the Faculty of Science, Helwan University, where she has been contributing since 2021. Prior to this, she held the position of Associate Professor of Organic Chemistry at the same institution from 2016 to 2021, demonstrating her upward trajectory in academia.

Her teaching and research influence extended beyond Egypt. She has held positions as an Associate Professor at Taibah University in Saudi Arabia, Nigerian Turkish Nile University in Nigeria, and the American University in Nigeria, where she was a co-founder of the Petroleum Chemistry Program. Additionally, she has served as a Visiting Professor at Virginia Commonwealth University in 2024, further showcasing her international academic reach.

Contributions and Research Focus 🔬

Prof. Azzam’s research focuses on organic and medicinal chemistry, with a particular emphasis on green synthesis, nanomaterials, and antiviral agents. One of her key research interests is the development of new methods for synthesizing compounds with potential anticancer and antimicrobial properties. Her recent project, “Synthesis of new sulfa derivatives under ultrasonic irradiation as potential anticancer/antimicrobial agents,” funded by Helwan University in 2021, highlights her innovative approach to organic synthesis.

Prof. Azzam’s work also explores environmentally friendly technologies, as demonstrated by her research on “green technology based on nanoporous biodegradable polymeric membranes” for wastewater treatment, funded by the Academy of Scientific Research Technology (ASRT). She has also conducted pioneering work on nanomaterials and their applications in industrial processes, such as her research on thermoplastic elastomers based on petrochemicals and the development of anti-COVID-19 agents incorporated into nanofibrous mats.

Her research output is extensive, and she has presented several projects on global platforms, including her work on antiviral therapeutic agents and nanomaterials. Her research contributions are shaping the future of organic chemistry, particularly in the domains of green chemistry and medical applications.

Accolades and Recognition 🏆

Prof. Azzam’s excellence in research and community service has been recognized through numerous awards and honors. In 2023, she received the prestigious Prince Mohammed Bin Fahd Scientific Award for her contributions to scientific production that serves community development within the framework of sustainable development goals. In the same year, she was honored with Helwan University’s Outstanding Scientific Achievement Award in Basic and Applied Sciences.

She has also been recognized for her mentoring and supervision of students, receiving Best Master Thesis Awards for two of her master’s students, Rasha Essam (2020) and Heba Elboshi (2023). Her commitment to advancing research was further acknowledged when she received the Research Excellence Awards for her students, Rokia Ramadan (2019) and Rasha Essam (2020). Additionally, Prof. Azzam was awarded a Silver Medal from the Academy of Scientific Research Technology (ASRT) in 2018 for her outstanding contributions to science.

Her impact extends internationally, with her receiving the Outstanding Faculty Member Award from the American University in Nigeria in 2007, and a research scholarship from the Catholic University of Leuven in 2001.

Impact and Influence 🌍

Prof. Azzam’s influence is felt not only through her research but also through her active participation in the scientific community. She serves as a Review Editor for Organic Chemistry on the Editorial Board of Frontiers in Chemistry and as an editor for the Journal of Chemistry and The Scientific World Journal, both published by Hindawi. She is also a grant evaluator for the Fulbright Binational Scholarship Program, where she helps assess the next generation of academic leaders.

Her commitment to education and community service is reflected in her involvement in organizing training workshops for high school teachers and instructing lab sessions for the AUN Community School. Prof. Azzam is also a member of the Egyptian Society for Basic Sciences, where she contributes to the development of the scientific community in Egypt.

Legacy and Future Contributions 🌟

Prof. Rasha A. Azzam’s legacy is built on her unwavering dedication to advancing organic chemistry, fostering academic excellence, and mentoring the next generation of scientists. Her research has laid the groundwork for significant developments in green chemistry, nanomaterials, and medicinal chemistry. With her continued focus on innovative solutions for pressing global challenges, such as wastewater treatment and the development of antiviral agents, she is poised to make even more impactful contributions in the years to come.

🎓Publication 

In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives

  • Authors   :Toka I. Ismail; Nashwa El-Khazragy; Rasha A. Azzam
  • Journal    :RSC Advances
  • Year         :2024

Novel High-Performance Functionalized and Grafted Bio-Based Chitosan Adsorbents for the Efficient and Selective Removal of Toxic Heavy Metals from Contaminated Water

  • Authors   :Mohammad Monir; Rasha E. Elsayed; Rasha Azzam; Tarek M. Madkour
  • Journal    :Polymers
  • Year         :2024

Crystal structure of 4-(benzo[d]thiazol-2-yl)-1,2-dimethyl-1H-pyrazol-3(2H)-one

  • Authors   :Heba A. Elboshi; Rasha A. Azzam; Galal H. Elgemeie; Peter G. Jones
  • Journal    :Acta Crystallographica Section E Crystallographic Communications
  • Year         :2024

Synthesis of New Guanidine Benzothiazole Derivative and Its Application as Eco-Friendly Corrosion Inhibitor

  • Authors   : Abdel-karim, Amal M.; Azzam, Rasha A.; Shehata, Omnia S.; Adly, Mohamed A.; El-Shamy, Omnia A. A.; El-Mahdy, Gamal A.
  • Journal    :Chemistry
  • Year         :2023

Crystal structure of 2-{[5-(methylsulfanyl)-4-phenyl-4H-1,2,4-triazol-3-yl]methyl}benzo[d]thiazole

  • Authors   : Rasha A. Azzam; Galal H. Elgemeie; Heba A. Elboshi; Peter G. Jones
  • Journal    :Crystallographica Section E Crystallographic Communications
  • Year         :2023